GLP-1 receptor agonists have become the most significant advancement in medical weight loss in decades. Originally developed for type 2 diabetes, these medications have demonstrated remarkable weight loss results — reshaping how clinicians approach chronic weight management.
If you're considering GLP-1 medications, this guide covers how they work, how the major options compare, what they cost, and how to determine which one is right for you.
How GLP-1 Medications Work
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces after eating. It signals to your brain that you're full, slows how quickly food leaves your stomach, and helps regulate blood sugar. GLP-1 medications are synthetic versions of this hormone, but they last much longer than the natural version — providing sustained appetite suppression throughout the week.
The key mechanisms:
- Appetite suppression — GLP-1 acts on the hypothalamus (the brain's hunger center) to reduce cravings and increase feelings of satiety
- Delayed gastric emptying — Food stays in your stomach longer, so you feel full faster and stay satisfied between meals
- Blood sugar regulation — Improved insulin sensitivity prevents the blood sugar spikes and crashes that trigger hunger
- Reduced food reward — Many patients report that hyper-palatable foods (sugary, fried, ultra-processed) simply become less appealing
GLP-1 Medications Compared
Here's how the leading GLP-1 weight loss medications stack up:
| Medication | Mechanism | Avg. Weight Loss | Dosing | FDA Approved for Weight Loss |
|---|---|---|---|---|
| Tirzepatide (Zepbound) | Dual GIP/GLP-1 | 18–22.5% | Weekly injection | Yes (Nov 2023) |
| Semaglutide (Wegovy) | GLP-1 only | 15–17% | Weekly injection | Yes (Jun 2021) |
| Liraglutide (Saxenda) | GLP-1 only | 5–8% | Daily injection | Yes (Dec 2014) |
| Retatrutide | Triple GIP/GLP-1/Glucagon | Up to 24%* | Weekly injection | Phase 3 trials |
*Retatrutide results are from Phase 2 clinical trials. Phase 3 data is pending.
Tirzepatide vs. Semaglutide: The Key Differences
The most common comparison patients ask about. Both are weekly injections, but they differ in important ways:
- Efficacy: Tirzepatide consistently shows 3–5% greater total body weight loss in head-to-head comparisons. The dual-receptor mechanism (GIP + GLP-1) provides stronger appetite suppression.
- Side effects: Both cause similar GI side effects (nausea, diarrhea). Some patients tolerate one better than the other — if you've struggled with semaglutide side effects, tirzepatide may be worth trying.
- Cost: Brand-name prices are comparable ($1,000–1,300/month without insurance). However, compounded versions through telehealth clinics like LAVIA significantly reduce costs.
- Availability: Semaglutide has been available longer and has broader supply. Tirzepatide availability has improved substantially since 2024.
What Results Can You Expect?
Individual results vary, but clinical trial data provides a useful benchmark:
- Month 1: 3–5 lbs lost. Appetite noticeably reduced. Cravings for processed foods diminish.
- Month 3: 8–15 lbs lost. Clothes fit differently. Energy levels improve.
- Month 6: 15–30 lbs lost. Significant changes in body composition. Blood markers (A1C, cholesterol, blood pressure) often improve.
- Month 12: 30–50+ lbs lost (depending on starting weight). Many patients reach their goal weight range.
The most successful patients combine GLP-1 medication with moderate lifestyle changes — not extreme diets, but consistent protein intake, regular movement, and adequate hydration.
How Much Do GLP-1 Medications Cost?
Cost is one of the biggest barriers to accessing GLP-1 medications. Here's the reality:
- Brand-name (retail pharmacy): $1,000–1,350/month without insurance
- With insurance: Varies widely. Some plans cover Wegovy/Zepbound for weight loss; many still don't. Copays range from $25–300/month.
- Compounded versions (telehealth): $99–399/month through clinics like LAVIA, which work with FDA-regulated compounding pharmacies
Telehealth platforms have made GLP-1 medications dramatically more accessible by offering compounded formulations at a fraction of the brand-name cost — without sacrificing quality or safety.
Are GLP-1 Medications Safe?
GLP-1 medications have been studied extensively. Semaglutide and tirzepatide have strong safety profiles established through clinical trials involving tens of thousands of participants. The most common side effects (nausea, GI discomfort) are typically mild and transient.
Important considerations:
- Not recommended during pregnancy or breastfeeding
- Contraindicated with personal/family history of medullary thyroid carcinoma
- Should be prescribed and monitored by a licensed clinician
- Regular check-ins help optimize dosing and manage any side effects
How to Get Started
LAVIA provides clinician-prescribed GLP-1 medications through a streamlined telehealth process. No waiting rooms, no insurance headaches. Complete a 5-minute health assessment, get matched with a licensed clinician, and receive your medication delivered to your door within 48 hours.
Ready to start your weight loss journey?
Complete a 5-minute online qualification to see if you're eligible for GLP-1 medication — delivered to your door in 48 hours.
Check if you qualify →